ClaritasRx

ClaritasRx (operating at claritasrx.com) is a data-driven analytics and patient engagement platform engineered for the biopharmaceutical industry. Founded in 2011 and headquartered in South San Francisco, California, ClaritasRx specializes in removing barriers that hinder patients’ access to rare disease and specialty treatments. Unlike traditional pharmacy solutions that focus solely on transactional data, ClaritasRx combines AI-driven market access insights with real-time patient analytics to optimize medication adherence and improve outcomes. Under the hood, its enterprise SaaS platform integrates data management, predictive analytics, and engagement tools, enabling seamless workflows for biopharma teams. This allows specialty brands to enhance fill rates, reduce attrition, and tailor interventions for high-risk patients. Backed by a $19.1M Series A funding round and strategic growth equity from Questa Capital, ClaritasRx is positioned to scale its technology while expanding its leadership team.